FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump
Status:
Completed
Trial end date:
2020-04-20
Target enrollment:
Participant gender:
Summary
This is an exploratory, single-center, randomized, open label, active-controlled, complete
cross-over trial comparing safety and efficacy of Fiasp® versus NovoLog® when used in the
Medtronic MiniMed 670G system in subjects with T1DM.